Drug distributor Cencora (NYSE:COR) agreed to repurchase shares of its common stock from Walgreens Boots Alliance (NASDAQ:WBA) for ~$50M in concurrence with Walgreens Boots Alliance’s sale of ...

Cencora, Inc. COR is well-poised for growth on the back of a robust U.S. Healthcare Solutions business and product launches.

Cencora is attractively valued for potentially strong total returns. Plus, with Walgreens' equity stake in COR reduced to just 6%, COR has more freedom to chart its own course.

Cencora's fiscal year 2025 guidance does not currently include the impact of the RCA acquisition, which will be incorporated following the transaction's close. THE LARGER TREND. Walgreens Boots ...

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount ...